| Alternative Name: | EPO |
| |
| MW: | Predicted MW of ~21kDa (single chain) and ~30kDa (glycosylated) |
| |
| Source: | Produced in CHO cells. |
| |
| UniProt ID: | P01588 |
| |
| Formulation: | Lyophilized. Each milligram contains 5.8mg sodium chloride and 0.06mg citric acid. Reconstitute with sterile 18W-cm water not <100μg/mL |
| |
| Purity: | ≥98% (SDS-PAGE; RP-HPLC) |
| |
| Purity Detail: | Purified by multi-step chromatography. |
| |
| Applications: | ELISA, WB
in vitro Assay
|
| |
| Application Notes: | Western blot control. |
| |
| Shipping: | Dry Ice |
| |
| Long Term Storage: | -20°C |
| |
| Scientific Background: | Erythropoietin (EPO) is a 34 kDa glycoprotein hormone produced by the kidney that promotes the formation of red blood cells in the bone marrow, thereby increasing the oxygen carrying capacity of blood in times of oxygen demand. |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
